Center for Pneumology, Donaustauf Hospital, Donaustauf, Germany.
Respir Care. 2013 Jul;58(7):1204-12. doi: 10.4187/respcare.01961. Epub 2012 Dec 4.
In patients with COPD, chronic anemia is known as an unfavorable prognostic factor. Whether the association between hemoglobin (Hb) levels and long-term survival is restricted to anemia or extends to higher Hb levels has not yet been systematically assessed.
We determined Hb levels in 309 subjects with COPD and chronic respiratory failure prior to initiation of noninvasive ventilation, accounting for confounders that might affect Hb. Subjects were categorized as anemic (Hb < 12 g/dL in females, Hb < 13 g/dL in males), polycythemic (Hb ≥ 15 g/dL in females, Hb ≥ 17 g/dL in males), or normocythemic. In addition, percentiles of Hb values were analyzed with regard to mortality from any cause.
Two-hundred seven subjects (67.0%) showed normal Hb levels, 46 (14.9%) had anemia, and 56 (18.1%) had polycythemia. Polycythemic subjects showed a higher survival rate than anemic (P = .01) and normocythemic subjects (P = .043). In a univariate Cox hazards model, Hb was associated with long-term survival (hazard ratio 0.855; 95% CI 0.783-0.934, P < .001). The 58th percentiles of Hb (14.3 g/dL in females, 15.1 g/dL in males) yielded the highest discriminative value for predicting survival (hazard ratio 0.463, 95% CI 0.324-0.660, P < .001). In the multivariate analysis this cutoff was an independent predictor for survival (hazard ratio 0.627, 95% CI 0.414-0.949, P = .03), in addition to age and body mass index.
In subjects with COPD and chronic respiratory failure undergoing treatment with noninvasive ventilation and LTOT, high Hb levels are associated with better long-term survival. The optimal cutoff level for prediction was above the established threshold defining anemia. Thus, predicting survival only on the basis of anemia does not fully utilize the prognostic potential of Hb values in COPD.
在 COPD 患者中,慢性贫血是一种不利的预后因素。血红蛋白(Hb)水平与长期生存之间的关联是否仅限于贫血,还是扩展到更高的 Hb 水平,尚未得到系统评估。
我们在开始无创通气之前,确定了 309 例 COPD 和慢性呼吸衰竭患者的 Hb 水平,考虑了可能影响 Hb 的混杂因素。将受试者分为贫血(女性 Hb < 12 g/dL,男性 Hb < 13 g/dL)、红细胞增多症(女性 Hb ≥ 15 g/dL,男性 Hb ≥ 17 g/dL)或正常 Hb 水平。此外,还分析了 Hb 值的百分位数与任何原因导致的死亡率之间的关系。
207 例(67.0%)患者 Hb 水平正常,46 例(14.9%)贫血,56 例(18.1%)红细胞增多症。红细胞增多症患者的生存率高于贫血(P =.01)和正常 Hb 水平(P =.043)患者。在单变量 Cox 风险模型中,Hb 与长期生存相关(风险比 0.855;95%CI 0.783-0.934,P <.001)。Hb 的第 58 个百分位数(女性 14.3 g/dL,男性 15.1 g/dL)对预测生存具有最高的区分价值(风险比 0.463,95%CI 0.324-0.660,P <.001)。在多变量分析中,该截点是生存的独立预测因素(风险比 0.627,95%CI 0.414-0.949,P =.03),除年龄和体重指数外。
在接受无创通气和 LTOT 治疗的 COPD 和慢性呼吸衰竭患者中,高 Hb 水平与长期生存相关。预测生存的最佳截断值高于定义贫血的既定阈值。因此,仅基于贫血来预测生存并不能充分利用 Hb 值在 COPD 中的预后潜力。